Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors. Whi W, Shin J, Kim JY, Ahn HK, et al. Breast Cancer Res 2025;27:134.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Whi W, Shin J, Kim JY, Ahn HK, et al. Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors. Breast Cancer Res 2025;27:134.
PMID: 40682137